JP2016506246A5 - - Google Patents

Info

Publication number

JP2016506246A5

JP2016506246A5 JP2015550478A JP2015550478A JP2016506246A5 JP 2016506246 A5 JP2016506246 A5 JP 2016506246A5 JP 2015550478 A JP2015550478 A JP 2015550478A JP 2015550478 A JP2015550478 A JP 2015550478A JP 2016506246 A5 JP2016506246 A5 JP 2016506246A5

Authority

JP

Japan

Prior art keywords

cells

medium

cell culture

culture system

triiodothyronine

Prior art date

2013-12-18

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004027 cell Anatomy 0.000 claims description 152
• 239000003112 inhibitor Substances 0.000 claims description 105
• AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims description 103
• 239000002609 medium Substances 0.000 claims description 94
• 238000000034 method Methods 0.000 claims description 87
• 108091005735 TGF-beta receptors Proteins 0.000 claims description 62
• 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 claims description 62
• 238000004113 cell culture Methods 0.000 claims description 62
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 58
• 229940035722 triiodothyronine Drugs 0.000 claims description 56
• 239000003550 marker Substances 0.000 claims description 51
• 239000001963 growth medium Substances 0.000 claims description 48
• 230000009996 pancreatic endocrine effect Effects 0.000 claims description 47
• XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 claims description 45
• 239000005495 thyroid hormone Substances 0.000 claims description 45
• 229940036555 thyroid hormone Drugs 0.000 claims description 45
• 229940034208 thyroxine Drugs 0.000 claims description 43
• XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 claims description 43
• 210000003890 endocrine cell Anatomy 0.000 claims description 39
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 36
• FOORCIAZMIWALX-ULJHMMPZSA-N (z)-n-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenylpyrazol-4-yl)methanimine Chemical compound CC1=NN(C=2C=CC=CC=2)C(C)=C1\C=N/N(CC1)CCN1CC1=CC=CC=C1 FOORCIAZMIWALX-ULJHMMPZSA-N 0.000 claims description 35
• CDOVNWNANFFLFJ-UHFFFAOYSA-N 4-[6-[4-(1-piperazinyl)phenyl]-3-pyrazolo[1,5-a]pyrimidinyl]quinoline Chemical compound C1CNCCN1C1=CC=C(C2=CN3N=CC(=C3N=C2)C=2C3=CC=CC=C3N=CC=2)C=C1 CDOVNWNANFFLFJ-UHFFFAOYSA-N 0.000 claims description 33
• 210000000130 stem cell Anatomy 0.000 claims description 31
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 30
• 229930002330 retinoic acid Natural products 0.000 claims description 30
• 229960001727 tretinoin Drugs 0.000 claims description 30
• 229960005070 ascorbic acid Drugs 0.000 claims description 29
• 235000010323 ascorbic acid Nutrition 0.000 claims description 29
• 239000011668 ascorbic acid Substances 0.000 claims description 29
• 102100028096 Homeobox protein Nkx-6.2 Human genes 0.000 claims description 28
• 101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims description 28
• 101000578258 Homo sapiens Homeobox protein Nkx-6.2 Proteins 0.000 claims description 28
• 239000000203 mixture Substances 0.000 claims description 28
• 210000001778 pluripotent stem cell Anatomy 0.000 claims description 27
• 210000002438 upper gastrointestinal tract Anatomy 0.000 claims description 27
• LBPKYPYHDKKRFS-UHFFFAOYSA-N 1,5-naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl]- Chemical group CC1=CC=CC(C2=C(C=NN2)C=2N=C3C=CC=NC3=CC=2)=N1 LBPKYPYHDKKRFS-UHFFFAOYSA-N 0.000 claims description 26
• 230000004069 differentiation Effects 0.000 claims description 25
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 19
• 239000005557 antagonist Substances 0.000 claims description 19
• 238000012258 culturing Methods 0.000 claims description 19
• 229960002897 heparin Drugs 0.000 claims description 19
• 229920000669 heparin Polymers 0.000 claims description 19
• 239000007788 liquid Substances 0.000 claims description 19
• 230000008410 smoothened signaling pathway Effects 0.000 claims description 19
• 102000004877 Insulin Human genes 0.000 claims description 18
• 108090001061 Insulin Proteins 0.000 claims description 18
• 229940125396 insulin Drugs 0.000 claims description 18
• 102000006533 chordin Human genes 0.000 claims description 17
• 108010008846 chordin Proteins 0.000 claims description 17
• NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 17
• 229960001763 zinc sulfate Drugs 0.000 claims description 17
• 229910000368 zinc sulfate Inorganic materials 0.000 claims description 17
• ZXSWZQSYZYMZKS-UHFFFAOYSA-N 2-methoxyethyl 4-(3-hydroxyphenyl)-7-(2-methoxyphenyl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1h-quinoline-3-carboxylate Chemical compound COCCOC(=O)C1=C(C)NC(CC(CC2=O)C=3C(=CC=CC=3)OC)=C2C1C1=CC=CC(O)=C1 ZXSWZQSYZYMZKS-UHFFFAOYSA-N 0.000 claims description 16
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 claims description 16
• 101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 claims description 16
• 210000004039 endoderm cell Anatomy 0.000 claims description 16
• 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 claims description 15
• 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 claims description 15
• QASFUMOKHFSJGL-LAFRSMQTSA-N Cyclopamine Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H](CC2=C3C)[C@@H]1[C@@H]2CC[C@@]13O[C@@H]2C[C@H](C)CN[C@H]2[C@H]1C QASFUMOKHFSJGL-LAFRSMQTSA-N 0.000 claims description 15
• 208000032740 autosomal recessive 10 intellectual disability Diseases 0.000 claims description 15
• QASFUMOKHFSJGL-UHFFFAOYSA-N cyclopamine Natural products C1C=C2CC(O)CCC2(C)C(CC2=C3C)C1C2CCC13OC2CC(C)CNC2C1C QASFUMOKHFSJGL-UHFFFAOYSA-N 0.000 claims description 15
• 239000012190 activator Substances 0.000 claims description 14
• 102000045246 noggin Human genes 0.000 claims description 14
• 108700007229 noggin Proteins 0.000 claims description 14
• BQJRUJTZSGYBEZ-YVQNUNKESA-N phorbol 12,13-dibutanoate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(=O)CCC)C1(C)C BQJRUJTZSGYBEZ-YVQNUNKESA-N 0.000 claims description 14
• 102100028412 Fibroblast growth factor 10 Human genes 0.000 claims description 13
• 101000917237 Homo sapiens Fibroblast growth factor 10 Proteins 0.000 claims description 13
• 102000013380 Smoothened Receptor Human genes 0.000 claims description 13
• 102000010792 Chromogranin A Human genes 0.000 claims description 12
• 108010038447 Chromogranin A Proteins 0.000 claims description 12
• BERLXWPRSBJFHO-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-n-pyridin-4-ylpteridin-4-amine Chemical compound FC1=CC=C(Cl)C=C1C1=NC(NC=2C=CN=CC=2)=C(N=CC=N2)C2=N1 BERLXWPRSBJFHO-UHFFFAOYSA-N 0.000 claims description 11
• 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 11
• 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 11
• 229940126864 fibroblast growth factor Drugs 0.000 claims description 11
• 239000002243 precursor Substances 0.000 claims description 10
• 239000000758 substrate Substances 0.000 claims description 10
• HIJMSZGHKQPPJS-UHFFFAOYSA-N 3-(6-methylpyridin-2-yl)-n-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide Chemical compound CC1=CC=CC(C=2C(=CN(N=2)C(=S)NC=2C=CC=CC=2)C=2C3=CC=CC=C3N=CC=2)=N1 HIJMSZGHKQPPJS-UHFFFAOYSA-N 0.000 claims description 8
• IHLVSLOZUHKNMQ-UHFFFAOYSA-N 4-[2-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxyethyl]morpholine Chemical compound C=1C=C2C(C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)=CC=NC2=CC=1OCCN1CCOCC1 IHLVSLOZUHKNMQ-UHFFFAOYSA-N 0.000 claims description 8
• FHYUGAJXYORMHI-UHFFFAOYSA-N SB 431542 Chemical compound C1=CC(C(=O)N)=CC=C1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 FHYUGAJXYORMHI-UHFFFAOYSA-N 0.000 claims description 8
• 210000001900 endoderm Anatomy 0.000 claims description 8
• ULFUJLFTRWWLPO-UHFFFAOYSA-N ethyl 2,7,7-trimethyl-5-oxo-4-(4-phenylphenyl)-1,4,6,8-tetrahydroquinoline-3-carboxylate Chemical compound CCOC(=O)C1=C(C)NC(CC(C)(C)CC2=O)=C2C1C(C=C1)=CC=C1C1=CC=CC=C1 ULFUJLFTRWWLPO-UHFFFAOYSA-N 0.000 claims description 8
• 108010090739 Smoothened Receptor Proteins 0.000 claims description 7
• 238000012606 in vitro cell culture Methods 0.000 claims description 7
• 101000576323 Homo sapiens Motor neuron and pancreas homeobox protein 1 Proteins 0.000 claims description 6
• 102100025170 Motor neuron and pancreas homeobox protein 1 Human genes 0.000 claims description 6
• 102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 claims description 6
• 101710183548 Pyridoxal 5'-phosphate synthase subunit PdxS Proteins 0.000 claims description 6
• 230000024245 cell differentiation Effects 0.000 claims description 6
• 238000004519 manufacturing process Methods 0.000 claims description 6
• 230000002124 endocrine Effects 0.000 claims description 5
• 102000052651 Pancreatic hormone Human genes 0.000 claims description 4
• 239000004025 pancreas hormone Substances 0.000 claims description 4
• 229940032957 pancreatic hormone Drugs 0.000 claims description 4
• 241000124008 Mammalia Species 0.000 claims description 3
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims description 3
• 238000001727 in vivo Methods 0.000 claims description 3
• 230000035800 maturation Effects 0.000 claims description 3
• 108010083123 CDX2 Transcription Factor Proteins 0.000 claims description 2
• 102100031671 Homeobox protein CDX-2 Human genes 0.000 claims description 2
• 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims description 2
• 101000711846 Homo sapiens Transcription factor SOX-9 Proteins 0.000 claims description 2
• 101000976653 Homo sapiens Zinc finger protein ZIC 1 Proteins 0.000 claims description 2
• 108700020479 Pancreatic hormone Proteins 0.000 claims description 2
• 102100024270 Transcription factor SOX-2 Human genes 0.000 claims description 2
• 102100034204 Transcription factor SOX-9 Human genes 0.000 claims description 2
• 102100023497 Zinc finger protein ZIC 1 Human genes 0.000 claims description 2
• 239000003102 growth factor Substances 0.000 claims description 2
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
• 239000003795 chemical substances by application Substances 0.000 claims 1
• 230000007423 decrease Effects 0.000 claims 1
• 230000005764 inhibitory process Effects 0.000 claims 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
• 239000000126 substance Substances 0.000 description 8
• 108091006082 receptor inhibitors Proteins 0.000 description 5
• -1 LYA2157299 Chemical compound 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 230000000968 intestinal effect Effects 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 210000001654 germ layer Anatomy 0.000 description 3
• 229940088597 hormone Drugs 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 230000001939 inductive effect Effects 0.000 description 3
• 101800001268 Pancreatic hormone Proteins 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 210000001161 mammalian embryo Anatomy 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 239000013589 supplement Substances 0.000 description 2
• WONYMNWUJVKVII-UHFFFAOYSA-N 3,5-diiodothyropropionic acid Chemical compound IC1=CC(CCC(=O)O)=CC(I)=C1OC1=CC=C(O)C=C1 WONYMNWUJVKVII-UHFFFAOYSA-N 0.000 description 1
• 102000018918 Activin Receptors Human genes 0.000 description 1
• 108010052946 Activin Receptors Proteins 0.000 description 1
• 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
• 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
• 210000002459 blastocyst Anatomy 0.000 description 1
• 210000003981 ectoderm Anatomy 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 210000003716 mesoderm Anatomy 0.000 description 1
• 238000010899 nucleation Methods 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 210000003577 pancreatic endocrine progenitor Anatomy 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 230000003068 static effect Effects 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1